|Chemical name: Pegfilgrastim
Typical dosage: 6mg/0.6ml
Typical type: Injection1
Neulasta® is a medication typically used to prevent chemotherapy-induced neutropenia (low white blood cells) and treat patients exposed to large doses of radiation. It is a brand only medication and is a subcutaneous injection into the fatty part of the skin.
Neulasta is a prescription medication that contains the active ingredient Pegfilgrastim. Neulasta is given once per chemotherapy cycle for prevention of cancer-induced neutropenia, and once weekly for patients who have been exposed to high doses of radiation (called hematopoietic radiation syndrome).
Neulasta stimulates the production, maturation and activation of neutrophils to improve the immune system.
The most common side effects with Neulasta include bone pain, muscle pain and pain in the arms or legs.
Yes! 64% of Medicare Advantage plans and Medicare Part D plans cover Neulasta.1
Drug coverage may vary based on plan availability. You may be able to find Medicare Advantage plan options in your area that cover Neulasta.
Find Medicare Advantage plans with drug coverageCompare Plans
Or call TTY Users: 711 24/7 to speak with a licensed insurance agent.
Your copay and deductible costs for any prescription drug can vary depending on what coverage stage you’re in.
|Deductible stage||Typical copay stage|
|Your deductible is the amount of money you must spend on covered drugs before your Medicare drug coverage starts paying its share of costs.
In the deductible stage, you’re responsible for the full cost of your prescription drugs.
Some Medicare prescription drug plans have a $0 deductible. Medicare drug plans cannot have a deductible more than $415 in 2019.
|After you meet your Part D deductible, you enter the initial coverage period.
During this phase (the typical copay stage), you pay a copayment (flat fee) or coinsurance (percentage) for your covered medications.
|$1,595 – $7,379||$1,463 – $7,166|
Neutropenia is when your white blood cell count is so low, your body is not able to adequately protect you from infections.
Neulasta is administered by a licensed healthcare provider in a healthcare setting.
Neulasta should be used with caution in patients with sickle cell anemia and may cause a condition called capillary leak syndrome. Capillary leak syndrome may lead to a heartbeat that is not normal, chest pain or pressure, heart attack, lung or breathing problems, bleeding or low blood flow in the stomach or bowel, swelling or feeling confused.
Talk to your doctor about the risks of infant exposure when using Nuelasta during pregnancy or while breastfeeding.
This article is for informational purposes only. It is not healthcare advice, treatment, or diagnosis. It is not an endorsement of or recommendation for this medication. Speak to your doctor or healthcare provider about your specific healthcare needs, including your prescription medications. Only take medication as directed by your doctor.
Coverage and costs of prescription medications will vary by Medicare plan. Not all plans are available in all areas.
Written by Hayden Gharibyar, Pharm.D.
Copyright © 2019 TZ Insurance Solutions LLC. All rights reserved.
1 GoodRx. Neulasta. Retrieved May 2019, from www.goodrx.com/neulasta.
2 Jacobson, Gretchen; et al. A Dozen Facts About Medicare Advantage. (Nov. 13, 2018). Kaiser Family Foundation. Retrieved from www.kff.org/medicare/issue-brief/a-dozen-facts-about-medicare-advantage.
MedicareAdvantage.com is a website owned and operated by TZ Insurance Solutions LLC. TZ Insurance Solutions LLC and TruBridge, Inc. represent Medicare Advantage Organizations and Prescription Drug Plans having Medicare contracts; enrollment in any plan depends upon contract renewal.
Plan availability varies by region and state. For a complete list of available plans, please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
Medicare has neither reviewed nor endorsed this information.